Mapping large numbers of results may take a few moments.
Search Results
Showing 201 - 210 of 210 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Vijaya Pharmaceuticals LLC | Activity: Contract Research and Testing | Company Description Vijaya Pharmaceuticals provides medicinal and synthetic organic chemistry services to the pharmaceutical and allied industries. | Location Research Triangle Park | |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham | |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham | |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point | |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham | |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill | |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill | |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh | |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |